We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CEM Signs Exclusive Licensing Agreement with SpheriTech

News   Feb 28, 2014

 
CEM Signs Exclusive Licensing Agreement with SpheriTech
 
 
Advertisement
 

RELATED ARTICLES

Why Is Obesity So Common in COVID-19 Patients? New Study Sheds Light

News

The Link May Be a Hormone that Regulates Appetite and the Immune System.

READ MORE

Wuhan COVID-19 Vaccine Trials Show Early Positive Results, Moving Forward to Phase 3 Testing

News

The adenovirus type-5-vectored COVID-19 vaccine was shown to be safe and induced significant immune responses in the majority of recipients after a single immunization.

READ MORE

Phase 1 Clinical Trial of University of Queensland COVID-19 Vaccine Begins

News

The first participants were enrolled into a Phase 1 clinical trial of the University of Queensland’s (UQ) COVID-19 vaccine candidate on July 13.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE